These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 7553067

  • 1. In vivo priming effects of interferon-beta ser on NK activity of peripheral blood mononuclear cells in cancer patients.
    Fujimiya Y, Wagner RJ, Groveman S, Sielaff K, Kohsaka T, Nakayama M.
    Ther Immunol; 1995 Feb; 2(1):15-22. PubMed ID: 7553067
    [Abstract] [Full Text] [Related]

  • 2. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J, Broxmeyer HE.
    Cell Immunol; 1997 Sep 15; 180(2):132-42. PubMed ID: 9341743
    [Abstract] [Full Text] [Related]

  • 3. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS, Hawkins MJ, Borden EC.
    Cancer Res; 1984 Jul 15; 44(7):3135-9. PubMed ID: 6586292
    [Abstract] [Full Text] [Related]

  • 4. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E, Kuranaga N, Satoh K, Habu Y, Shinomiya N, Asano T, Seki S, Hayakawa M.
    Scand J Immunol; 2007 Feb 15; 65(2):126-38. PubMed ID: 17257217
    [Abstract] [Full Text] [Related]

  • 5. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G, Esin S, Favilli F, Pardini M, Bottai D, Maisetta G, Florio W, Campa M.
    Scand J Immunol; 2005 Dec 15; 62(6):498-506. PubMed ID: 16316416
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity.
    Gatti G, Masera RG, Pallavicini L, Sartori ML, Staurenghi A, Orlandi F, Angeli A.
    Brain Behav Immun; 1993 Mar 15; 7(1):16-28. PubMed ID: 8386029
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
    Whiteside TL, Letessier E, Hirabayashi H, Vitolo D, Bryant J, Barnes L, Snyderman C, Johnson JT, Myers E, Herberman RB.
    Cancer Res; 1993 Dec 01; 53(23):5654-62. PubMed ID: 8242620
    [Abstract] [Full Text] [Related]

  • 11. Modulation of natural killing activity by lymphoblastoid interferon in cancer patients.
    Koren HS, Brandt CP, Tso CY, Laszlo J.
    J Biol Response Mod; 1983 Dec 01; 2(2):151-65. PubMed ID: 6644332
    [Abstract] [Full Text] [Related]

  • 12. Phenotypically and functionally distinct subsets of natural killer cells in human PBMCs.
    Fan YY, Yang BY, Wu CY.
    Cell Biol Int; 2008 Feb 01; 32(2):188-97. PubMed ID: 17920947
    [Abstract] [Full Text] [Related]

  • 13. Suppression of natural killer cell cytotoxicity in the peripheral blood of patients receiving interferon therapy.
    Spina CA, Fahey JL, Durkos-Smith D, Dorey F, Sarna G.
    J Biol Response Mod; 1983 Feb 01; 2(5):458-69. PubMed ID: 6644350
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of human natural killer cell cytotoxicity by recombinant leukocyte interferon clone A.
    Lotzová E, Savary CA, Gutterman JU, Quesada JR, Hersh EM.
    J Biol Response Mod; 1983 Feb 01; 2(5):482-96. PubMed ID: 6644351
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Exposure of NK cells to intravenous immunoglobulin induces IFN gamma release and degranulation but inhibits their cytotoxic activity.
    Jacobi C, Claus M, Wildemann B, Wingert S, Korporal M, Römisch J, Meuer S, Watzl C, Giese T.
    Clin Immunol; 2009 Dec 01; 133(3):393-401. PubMed ID: 19828380
    [Abstract] [Full Text] [Related]

  • 19. Natural killer (NK) cell activity of women with gross cystic disease is inhibited in vitro by breast cyst fluid.
    Ardizzoja M, Masera RG, Tacconis P, Sartori ML, Arisio R, Massobrio M, Angeli A.
    Anticancer Res; 1994 Dec 01; 14(2A):555-9. PubMed ID: 8017860
    [Abstract] [Full Text] [Related]

  • 20. Regulation of human natural cytotoxicity by IgG. III. Interaction between negative regulation by monomeric IgG and positive regulation by interferons of different types.
    Sulica A, Gherman M, Manciulea M, Galatiuc C, Herberman RB.
    Nat Immun Cell Growth Regul; 1989 Dec 01; 8(5):266-78. PubMed ID: 2480519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.